NEW YORK (GenomeWeb News) – Roche said Monday that it will distribute two cancer mutation tests for the UK molecular diagnostics company DxS.
 
DxS makes companion diagnostics that can be used by oncologists to aid in the prognosis and development of treatments for cancer patients based on specific gene mutations, Roche said.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.

In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.